This head-to-head pharmacodynamic study in healthy volunteers examined the ability of both OPVEE and intranasal naloxone to reverse opioid-induced respiratory…
NEW YORK, March 11, 2024 /PRNewswire/ — Tech innovators, victim-survivor advocates, policy makers and thinkers are invited to showcase their transformative…